DoD Peer Reviewed Medical Research Program, Technology/Therapeutic Development Award
Closed Posted
- Opportunity number
- HT942525PRMRPTTDA
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
- Funding instrument
- Cooperative Agreement, Grant
- Category
-
- Science and Technology and other Research and Development
- Eligible applicants
-
- Unrestricted
- Points of contact
-
- eBRAP Help Desk help@ebrap.org (301) 682-5507
Opportunity details come from Grants.gov. Updated .
About this opportunity
The Department of the Army Medical Command is seeking applications for the Fiscal Year 2025 Peer Reviewed Medical Research Program (PRMRP) Technology/Therapeutic Development Award (TTDA). This product-driven award mechanism aims to support the translation of promising preclinical research into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life, for diseases or conditions related to the FY25 PRMRP topic areas and strategic goals. Eligible applicants include extramural and intramural organizations, both foreign and domestic, for-profit and non-profit, with Principal Investigators at or above the Assistant Professor level. The program expects the research proposed will take an already established proof-of-concept or prototype through the final stages of preclinical development, with the outcome being a regulatory filing or translation of findings into clinical practice.
The Department of the Army Medical Command anticipates allocating approximately $41.25 million to fund approximately 11 TTDA applications. Each award will have a maximum total cost of $2.5 million and a performance period of up to 4 years. The pre-application deadline is June 9, 2025, and the full application deadline is July 21, 2025, with peer and programmatic reviews occurring in September/October and December 2025, respectively.
Synopsis
Summary: The fiscal year 2025 (FY25) Peer Reviewed Medical Research Program (PRMRP) Technology/Therapeutic Development Award (TTDA) is a product-driven award mechanism intended to provide support for the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life, for a disease or condition related to one of the FY25 PRMRP topic areas and one of the FY25 PRMRP strategic goals. Products can be tangible items, such as drugs or devices, or can be knowledge products, such as clinical decision making tools or practice guidelines. Products in development should be responsive to the health care needs of military Service Members, Veterans, and their Families.
Distinctive Features: For the PRMRP TTDA, the program expects the research proposed will take an already established proof-of-concept or prototype through the final stages of preclinical development. The PRMRP also expects that the research outcome will be a regulatory filing or translation of findings into clinical practice, as applicable.
Files
| File | Type | Posted |
|---|---|---|
| HT942525PRMRPTTDA-GG.pdf | ||
| HT942525PRMRPTTDA-GG2.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity